Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups

View source ↗

Summary

A pediatric clinical trial is evaluating gut microbiota diversity in children aged 1-3 on prolonged antibiotic prophylaxis for grade 3 or higher vesicoureteral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Vesicoureteral Reflux 3 | Status: RECRUITING